Disease‐duration based comparison of subsets of immune cells in SARS CoV‐2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity

INTRODUCTION: Infection with SARS‐CoV‐2 leads to a spectrum of symptoms. Understanding the basis for severity remains crucial for better management and therapy development. So far, older age, associated‐comorbidities, and IL‐6 have been associated with severity/mortality. MATERIALS AND METHODOLOGY:...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulkarni‐Munje, Archana, Palkar, Sonali, Shrivastava, Shubham, Lalwani, Sanjay, Mishra, Akhilesh C., Arankalle, Vidya A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014065/
https://www.ncbi.nlm.nih.gov/pubmed/33452858
http://dx.doi.org/10.1002/iid3.402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014065/
https://www.ncbi.nlm.nih.gov/pubmed/33452858
http://dx.doi.org/10.1002/iid3.402

Ejemplares similares